Description
1. Talatisamine (12 uM) and TEA (5mM) inhibits the enhanced I(K) caused by Abeta4 oligomers, attenuates cytotoxicity of Abeta oligomers by restoring cell viability and suppressing K(+) loss related apoptotic response. 2. Talatisamine can therefore be considered as a leading compound worthy of further investigations